Ideas For Profit | Will Sun Pharma’s steady India business, US speciality portfolio help it do well in FY22?

In this edition of Ideas For Profit, Moneycontrol#39;s Sakshi Batra decodes Sun Pharma Q1 results and suggests what strategy investors could adopt now.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/ideas-for-profit-|-will-sun-pharma’s-steady-india-business-us-speciality-portfolio-help-it-do-wellfy22_14116101.html